Contact this trialFirst, we need to learn more about you.
Janus Kinase (JAK) Inhibitor
Deucravacitinib for Psoriasis
Recruiting2 awardsPhase 4
Newmarket, Ontario
This trial will test a drug to see if it can help people with psoriasis on their hands, feet, and genitals.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.